| Name | Number Pages |
|---|
| research | 57 |
| subjects | 47 |
| irb | 42 |
| human subjects | 41 |
| subject | 40 |
| information | 40 |
| available | 36 |
| investigator | 35 |
| procedures | 35 |
| informed consent | 35 |
| use | 35 |
| more | 34 |
| study | 34 |
| risks | 34 |
| individual | 33 |
| such | 33 |
| consent | 32 |
| 2 | 32 |
| investigators | 32 |
| appropriate | 32 |
| requirements | 32 |
| part | 32 |
| one | 31 |
| b | 31 |
| regulations | 31 |
| e.g. | 31 |
| human subjects research | 30 |
| review | 30 |
| participation | 29 |
| c | 28 |
| time | 28 |
| accordance | 28 |
| data | 28 |
| 3 | 28 |
| form | 27 |
| 1 | 27 |
| top | 27 |
| example | 27 |
| applicable | 26 |
| application | 26 |
| persons | 26 |
| person | 26 |
| approval | 26 |
| studies | 26 |
| section | 25 |
| addition | 25 |
| institutional review board | 24 |
| course | 24 |
| institution | 24 |
| purposes | 24 |
| purpose | 24 |
| individuals | 24 |
| following | 24 |
| children | 24 |
| office | 24 |
| responsible | 23 |
| protection | 23 |
| compliance | 23 |
| activities | 23 |
| 5 | 23 |
| records | 23 |
| able | 23 |
| minimal risk | 23 |
| project | 22 |
| irb office | 22 |
| risk | 22 |
| rights | 22 |
| 4 | 22 |
| protocol | 21 |
| conduct | 21 |
| food | 21 |
| drug administration | 21 |
| fda | 20 |
| health | 20 |
| results | 20 |
| condition | 20 |
| necessary | 20 |
| nature | 20 |
| benefits | 19 |
| research subjects | 19 |
| statement | 19 |
| order | 19 |
| copy | 19 |
| state | 19 |
| criteria | 19 |
| researchers | 19 |
| experience | 19 |
| responsibility | 19 |
| limited | 18 |
| other | 18 |
| case | 18 |
| possible | 18 |
| conditions | 18 |
| others | 18 |
| welfare | 18 |
| cannot | 18 |
| decision | 18 |
| extent | 18 |
| institutions | 18 |
| cases | 18 |
| physical | 18 |
| paragraph | 18 |
| effect | 18 |
| tests | 17 |
| e | 17 |
| scope | 17 |
| uiuc | 17 |
| respect | 17 |
| ii | 17 |
| access | 17 |
| exception | 17 |
| university of illinois | 17 |
| effects | 17 |
| writing | 17 |
| determination | 17 |
| proposed research | 17 |
| date | 17 |
| opportunity | 16 |
| investigation | 16 |
| will | 16 |
| need | 16 |
| questions | 16 |
| confidentiality | 16 |
| human services | 16 |
| request | 16 |
| iii | 16 |
| completion | 16 |
| changes | 16 |
| development | 16 |
| safe | 15 |
| drugs | 15 |
| description | 15 |
| greater | 15 |
| terms | 15 |
| irbs | 15 |
| notice | 15 |
| sponsor | 15 |
| responsible project investigator | 15 |
| rpi | 15 |
| initial | 15 |
| research protocol | 15 |
| projects | 15 |
| requirement | 15 |
| place | 15 |
| meeting | 15 |
| circumstances | 15 |
| required | 15 |
| inclusion | 15 |
| staff | 15 |
| employee | 14 |
| belmont report | 14 |
| assent | 14 |
| agency | 14 |
| research project | 14 |
| research activities | 14 |
| irb approval | 14 |
| effectiveness | 14 |
| 6 | 14 |
| language | 14 |
| waiver | 14 |
| procedure | 14 |
| consent form | 14 |
| note | 14 |
| prisoners | 14 |
| human subject | 14 |
| protocols | 14 |
| 7 | 14 |
| reasonable | 13 |
| safety | 13 |
| account | 13 |
| student | 13 |
| documentation | 13 |
| such research | 13 |
| guidelines | 13 |
| patients | 13 |
| sufficient | 13 |
| manner | 13 |
| period | 13 |
| effective | 13 |
| complete | 13 |
| vice chancellor | 13 |
| name | 13 |
| physician | 13 |
| location | 13 |
| end | 13 |
| consideration | 13 |
| members | 13 |
| event | 13 |
| federal | 13 |
| term | 13 |
| sec | 13 |
| pregnant women | 13 |
| care | 13 |
| federal regulations | 13 |
| intervention | 12 |
| exemption | 12 |
| general | 12 |
| policy | 12 |
| decisions | 12 |
| research subject | 12 |
| 1996 | 12 |
| obligation | 12 |
| clinical investigation | 12 |
| performance | 12 |
| research study | 12 |
| result | 12 |
| advice | 12 |
| disease | 12 |
| serious | 12 |
| regard | 12 |
| involvement | 12 |
| law | 12 |
| students | 12 |
| methods | 12 |
| exempt | 12 |
| elements | 12 |
| irb review | 12 |
| public | 12 |
| responses | 12 |
| parents | 12 |
| research purposes | 12 |
| policies | 12 |
| representative | 12 |
| funding | 12 |
| additional information | 12 |
| humans | 12 |
| g | 12 |
| department of health | 12 |
| uiuc irb | 11 |
| federal register | 11 |
| groups | 11 |
| behalf | 11 |
| likely | 11 |
| urbana champaign | 11 |
| details | 11 |
| standards | 11 |
| provisions | 11 |
| participant | 11 |
| definition | 11 |
| formal | 11 |
| act | 11 |
| document | 11 |
| applications | 11 |
| site | 11 |
| observation | 11 |
| observations | 11 |
| social | 11 |
| identifiable information | 11 |
| 45 cfr 46 | 11 |
| entity | 11 |
| can | 11 |
| documents | 11 |
| participants | 11 |
| judgment | 11 |
| following information | 11 |
| reasons | 11 |
| reviews | 11 |
| principles | 11 |
| examples | 11 |
| hhs | 11 |
| agreement | 11 |
| basis | 11 |
| age | 11 |
| services | 11 |
| submission | 11 |
| evaluation | 11 |
| committee | 11 |
| authority | 11 |
| chapter | 10 |
| plan | 10 |
| modifications | 10 |
| understanding | 10 |
| letter | 10 |
| individual subjects | 10 |
| differences | 10 |
| investigations | 10 |
| consent process | 10 |
| method | 10 |
| practice | 10 |
| ohrp | 10 |
| receipt | 10 |
| injury | 10 |
| copies | 10 |
| child | 10 |
| education | 10 |
| activity | 10 |
| permission | 10 |
| top sec | 10 |
| different | 10 |
| compensation | 10 |
| reports | 10 |
| probability | 10 |
| researcher | 10 |
| code of federal | 10 |
| privacy | 10 |
| voluntary | 10 |
| pdf | 10 |
| anticipated benefits | 10 |
| way | 10 |
| employees | 10 |
| present | 10 |
| drug | 10 |
| laws | 10 |
| change | 10 |
| 1998 | 10 |
| design | 10 |
| important | 10 |
| protection of human subjects | 10 |
| 2000 | 10 |
| explanation | 10 |
| context | 10 |
| reporting | 10 |
| fact | 9 |
| sponsors | 9 |
| local laws | 9 |
| h | 9 |
| ethical principles | 9 |
| interviews | 9 |
| effective informed consent | 9 |
| interventions | 9 |
| fetuses | 9 |
| treatments | 9 |
| devices | 9 |
| assurance | 9 |
| importance | 9 |
| monitoring | 9 |
| class | 9 |
| control | 9 |
| dhhs | 9 |
| assessment | 9 |
| consent document | 9 |
| part 50 | 9 |
| board | 9 |
| interaction | 9 |
| determinations | 9 |
| applicability | 9 |
| coercion | 9 |
| oct. 2 | 9 |
| adequate provision | 9 |
| identifiers | 9 |
| knowledgeable | 9 |
| medical | 9 |
| criminal | 9 |
| applicable federal | 9 |
| knowledge | 9 |
| irb members | 9 |
| patient | 9 |
| notification | 9 |
| potential risks | 9 |
| contracts | 9 |
| reason | 9 |
| might | 9 |
| emotional | 9 |
| diagnostic | 9 |
| uiuc policies | 9 |
| question | 9 |
| institutional review boards | 9 |
| report | 9 |
| relation | 9 |
| benefit | 9 |
| identification | 9 |
| file | 9 |
| absence | 9 |
| responsibilities | 9 |
| actions | 9 |
| particular | 9 |
| consistent | 9 |
| first | 9 |
| collection | 9 |
| trial | 9 |
| human research protections | 9 |
| eligible | 9 |
| agent | 9 |
| applicable law | 9 |
| prospect | 9 |
| consent forms | 9 |
| direct benefit | 9 |
| surveys | 9 |
| irb application | 9 |
| potential | 9 |
| investigational new drug | 8 |
| common rule | 8 |
| states | 8 |
| ind | 8 |
| essential | 8 |
| statute | 8 |
| department | 8 |
| psychological examinations | 8 |
| majority | 8 |
| clear | 8 |
| acceptability | 8 |
| initiation | 8 |
| delivery | 8 |
| objectives | 8 |
| life | 8 |
| psychological | 8 |
| reviewers | 8 |
| material | 8 |
| alternatives | 8 |
| routine physical | 8 |
| group | 8 |
| 50.24 | 8 |
| unanticipated problems | 8 |
| j | 8 |
| director | 8 |
| implementation | 8 |
| regulation | 8 |
| society | 8 |
| aware | 8 |
| body | 8 |
| examination | 8 |
| 1999 | 8 |
| frequency | 8 |
| gender | 8 |
| nih | 8 |
| hospital | 8 |
| subpart | 8 |
| process | 8 |
| items | 8 |
| contact | 8 |
| level | 8 |
| programs | 8 |
| categories | 8 |
| part 56 | 8 |
| problems | 8 |
| expedited review | 8 |
| address | 8 |
| treatment | 8 |
| informed consent process | 8 |
| version | 8 |
| proposals | 8 |
| testing | 8 |
| magnitude | 8 |
| less | 8 |
| obligations | 8 |
| minor changes | 8 |
| death | 8 |
| disclosure | 8 |
| iv | 8 |
| materials | 8 |
| investigational device exemption | 7 |
| advance | 7 |
| meetings | 7 |
| generalizable knowledge | 7 |
| summary | 7 |
| 2002 | 7 |
| practices | 7 |
| agencies | 7 |
| principal investigator | 7 |
| written consent | 7 |
| incompetent | 7 |
| record | 7 |
| one member | 7 |
| experiment | 7 |
| hhs regulations | 7 |
| sufficient information | 7 |
| professionals | 7 |
| handbook | 7 |
| relevant | 7 |
| conclusion | 7 |
| marketing application | 7 |
| adverse events | 7 |
| 30 days | 7 |
| united states | 7 |
| enrollment | 7 |
| etc. | 7 |
| names | 7 |
| discomfort | 7 |
| clinical | 7 |
| proposal | 7 |
| new | 7 |
| needed | 7 |
| click | 7 |
| irb web site | 7 |
| ethical | 7 |
| action | 7 |
| measures | 7 |
| selection of subjects | 7 |
| danger | 7 |
| investigational new drug application | 7 |
| status | 7 |
| many | 7 |
| substance | 7 |
| v | 7 |
| value | 7 |
| research activity | 7 |
| assurances | 7 |
| clinical studies | 7 |
| feasible | 7 |
| duration | 7 |
| support | 7 |
| same | 7 |
| uiuc institutional review board | 7 |
| women | 7 |
| clinical investigations | 7 |
| chapter 6 | 7 |
| biomedical | 7 |
| tissues | 7 |
| public health service act | 7 |
| definitions | 7 |
| quality | 7 |
| fetus | 7 |
| resolution | 7 |
| other information | 7 |
| instructions | 7 |
| acceptable | 7 |
| country | 7 |
| forms | 7 |
| ethics | 7 |
| undue influence | 7 |
| discussion | 7 |
| objective | 7 |
| clinical trials | 7 |
| contents | 7 |
| distribution | 7 |
| following requirements | 7 |
| 1997 | 7 |
| presentation | 7 |
| center | 7 |
| situations | 7 |
| guidance | 7 |
| vulnerable | 7 |
| identity | 7 |
| minimal | 7 |
| degree of risk | 7 |
| adequate | 6 |
| daily life | 6 |
| federal policy | 6 |
| ability | 6 |
| familiar | 6 |
| point | 6 |
| distinguished | 6 |
| two | 6 |
| release | 6 |
| professional | 6 |
| d | 6 |
| progress reports | 6 |
| availability | 6 |
| ms word | 6 |
| conduct of research | 6 |
| behavioral research | 6 |
| difficult | 6 |
| title | 6 |
| national institutes of health | 6 |
| position | 6 |
| capable | 6 |
| public behavior | 6 |
| composition | 6 |
| 1991 | 6 |
| principal risk | 6 |
| controls | 6 |
| interview procedures | 6 |
| subject participation | 6 |
| expertise | 6 |
| exemptions | 6 |
| medical device | 6 |
| investigational drug | 6 |
| whole | 6 |
| ethical standards | 6 |
| mar. 4 | 6 |
| marketing approval | 6 |
| sections | 6 |
| contrary | 6 |
| ways | 6 |
| part 46 | 6 |
| other research | 6 |
| living individual | 6 |
| pdf fillable form | 6 |
| plans | 6 |
| magnitude of harm | 6 |
| foreign countries | 6 |
| questionnaires | 6 |
| scientific | 6 |
| uses | 6 |
| part 16 | 6 |
| chemical | 6 |
| timing | 6 |
| fair | 6 |
| intent | 6 |
| set | 6 |
| people | 6 |
| medicine | 6 |
| relationship | 6 |
| new information | 6 |
| 1987 | 6 |
| issues | 6 |
| one parent | 6 |
| phone | 6 |
| environmental protection agency | 6 |
| applicant | 6 |
| ide | 6 |
| device | 6 |
| training | 6 |
| reputation | 6 |
| medical care | 6 |
| evidence | 6 |
| member | 6 |
| true | 6 |
| existence | 6 |
| maturity | 6 |
| long | 6 |
| informed consent document | 6 |
| web site | 6 |
| selection | 6 |
| adobe acrobat reader | 6 |
| full adobe acrobat application | 6 |
| 45 cfr part 46 | 6 |
| pdf available | 6 |
| three years | 6 |
| faculty | 6 |
| breach of confidentiality | 6 |
| comparison | 6 |
| possibility | 6 |
| populations | 6 |
| understandable | 6 |
| secretary | 6 |
| title 45 | 6 |
| subject groups | 6 |
| 45 cfr | 6 |
| prior | 6 |
| weight | 6 |
| matter | 6 |
| research risks | 6 |
| alteration | 6 |
| stipulations | 6 |
| outcomes | 6 |
| characteristics | 6 |
| template | 6 |
| inspection | 6 |
| service programs | 6 |
| more information | 6 |
| pregnant | 6 |
| secretary of hhs | 6 |
| survey | 6 |
| irb purposes | 6 |
| acrobat reader | 6 |
| 1990 | 6 |
| 56 | 6 |
| psychological state | 6 |
| nonscientific areas | 6 |
| consultation | 6 |
| due diligence | 6 |
| therapy | 6 |
| appropriate institutional officials | 6 |
| payment | 6 |
| connection | 6 |
| 2001 | 6 |
| much | 6 |
| primary concerns | 6 |
| list | 6 |
| recommendations | 6 |
| observed | 6 |
| administration | 6 |
| research context | 6 |
| uiuc handbook | 6 |
| capacity | 6 |
| agents | 6 |
| answers | 6 |
| initiates | 6 |
| correspondence | 6 |
| category | 6 |
| suspension | 6 |
| ind. | 6 |
| inconsistent | 6 |
| research results | 6 |
| guardian | 6 |
| year | 6 |
| contract | 5 |
| institutional commitments | 5 |
| public health | 5 |
| mental | 5 |
| environmental contaminant | 5 |
| uiuc federalwide assurance | 5 |
| legal age | 5 |
| number | 5 |
| disabled persons | 5 |
| satisfies | 5 |
| comparable | 5 |
| k | 5 |
| clients | 5 |
| inventories | 5 |
| attendance | 5 |
| irb meeting | 5 |
| federal food | 5 |
| workshop | 5 |
| privacy of subjects | 5 |
| june 17 | 5 |
| goals | 5 |
| background | 5 |
| personnel | 5 |
| investigational plan | 5 |
| termination | 5 |
| wholesome foods | 5 |
| introduction | 5 |
| subpart d | 5 |
| discretion | 5 |
| consent documents | 5 |
| review procedures | 5 |
| more experienced reviewers | 5 |
| type | 5 |
| harm | 5 |
| venipuncture | 5 |
| equivalent | 5 |
| complies | 5 |
| human use | 5 |
| following categories | 5 |
| educational tests | 5 |
| vitro | 5 |
| aspects | 5 |
| 9 | 5 |
| product | 5 |
| free | 5 |
| hypothesis | 5 |
| manner consistent | 5 |
| course projects | 5 |
| vulnerable populations | 5 |
| parent | 5 |
| clinical trial | 5 |
| possible benefits | 5 |
| campus | 5 |
| additional pertinent information | 5 |
| products | 5 |
| brief description | 5 |
| confidentiality of data | 5 |
| human being | 5 |
| achievement | 5 |
| continuation | 5 |
| . | 5 |
| determined | 5 |
| nonpublic information | 5 |
| detail | 5 |
| irb approval of research | 5 |
| 61 fr 51530 | 5 |
| prospective subject | 5 |
| experienced | 5 |
| 52 fr 8831 | 5 |
| broad | 5 |
| accord | 5 |
| fall | 5 |
| cognitive | 5 |
| additives | 5 |
| cosmetic act | 5 |
| noncompliance | 5 |
| financial standing | 5 |
| seq | 5 |
| recommendation | 5 |
| irb meetings | 5 |
| 52 fr 23031 | 5 |
| grants | 5 |
| cooperation | 5 |
| paragraphs | 5 |
| primary responsibility | 5 |
| drug product | 5 |
| fluids | 5 |
| function | 5 |
| employability | 5 |
| cause | 5 |
| damaging | 5 |
| jan. 27 | 5 |
| other means | 5 |
| voluntary participation | 5 |
| written | 5 |
| unable | 5 |
| inquiries | 5 |
| publication | 5 |
| mri | 5 |
| progress | 5 |
| early | 5 |
| requirements of sec | 5 |
| research projects | 5 |
| consumer acceptance studies | 5 |
| commissioner | 5 |
| civil liability | 5 |
| justified | 5 |
| ies | 5 |
| appropriate body | 5 |
| clinical study | 5 |
| further | 5 |
| reviewer | 5 |
| 1981 | 5 |
| degrees | 5 |
| contact information | 5 |
| means | 5 |
| illness | 5 |
| three | 5 |
| immediate direction | 5 |
| fda regulations | 5 |
| findings | 5 |
| food safety | 5 |
| human research subjects | 5 |
| test article | 5 |
| emergency | 5 |
| mar. 19 | 5 |
| physicians | 5 |
| food ingredient | 5 |
| annual reports | 5 |
| significant | 5 |
| uiuc employee | 5 |
| inspection service | 5 |
| uiuc faculty | 5 |
| management | 5 |
| clinical investigator | 5 |
| uiuc irb office | 5 |
| expedited review procedure | 5 |
| short form | 5 |
| continuing review | 5 |
| federal government | 5 |
| disapproval | 5 |
| medical record | 5 |
| home | 5 |
| secs | 5 |
| study design | 5 |
| chair | 5 |
| person other | 5 |
| part 314 | 5 |
| same time | 5 |
| ohrp guidebook research | 5 |
| minimal risk of harm | 5 |
| membership | 5 |
| copying | 5 |
| communication | 5 |
| issue | 5 |
| research amendment form | 5 |
| significant new findings | 5 |
| reasonable times | 5 |
| commensurate | 5 |
| analysis | 5 |
| equipment | 5 |
| intervals appropriate | 5 |
| employment | 5 |
| 46.116 | 5 |
| informed consent requirement | 4 |
| protection of subjects | 4 |
| little information | 4 |
| limit | 4 |
| anonymity | 4 |
| normal | 4 |
| campus policies | 4 |
| 45 cfr 46.116 | 4 |
| expiration date | 4 |
| authorized official | 4 |
| severity | 4 |
| product development protocol | 4 |
| 312.32 | 4 |
| persistent | 4 |
| comment | 4 |
| 8th grade reading level | 4 |
| other relevant ethical concerns | 4 |
| alcoholism | 4 |
| biomedical research | 4 |
| additional experience | 4 |
| title 45 code of federal | 4 |
| burdens | 4 |
| essential elements | 4 |
| routine course | 4 |
| modification | 4 |
| survey procedures | 4 |
| decline | 4 |
| uses one | 4 |
| manufacturing | 4 |
| careful | 4 |
| preferable | 4 |
| certification | 4 |
| dhhs regulations | 4 |
| adequacy | 4 |
| physical procedures | 4 |
| may | 4 |
| scientific research | 4 |
| side effects | 4 |
| team | 4 |
| statements | 4 |
| addresses | 4 |
| aptitude | 4 |
| irb member | 4 |
| fetal material | 4 |
| sufficient opportunity | 4 |
| commitment | 4 |
| subject environment | 4 |
| more individuals | 4 |
| approval of department | 4 |
| content | 4 |
| 8 | 4 |
| ascertain | 4 |
| situation | 4 |
| setting | 4 |
| potential harm | 4 |
| assistance | 4 |
| duties | 4 |
| other agency | 4 |
| institutional official | 4 |
| applicable policies | 4 |
| sept. 5 | 4 |
| refusal | 4 |
| behavior | 4 |
| departmental review committee | 4 |
| oral process | 4 |
| public officials | 4 |
| of women | 4 |
| subject privacy | 4 |
| clinical investigators | 4 |
| experts | 4 |
| handicapped | 4 |
| number of subjects | 4 |
| hold | 4 |
| potential benefits | 4 |
| 20 | 4 |
| written summary | 4 |
| medical devices | 4 |
| prior irb approval | 4 |
| only involvement | 4 |
| 1989 | 4 |
| standard requirements | 4 |
| virtue | 4 |
| oral | 4 |
| 1 year | 4 |
| identifiable private information | 4 |
| references | 4 |
| other parameters | 4 |
| investigational use | 4 |
| manipulations | 4 |
| backgrounds | 4 |
| photos | 4 |
| individual students | 4 |
| immediate | 4 |
| responsible leader | 4 |
| 12420 parklawn dr. | 4 |
| top placeholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder text textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder textplaceholder | 4 |
| project investigator | 4 |
| 1980 | 4 |
| such issues | 4 |
| authorization | 4 |
| primary purpose | 4 |
| instances | 4 |
| right | 4 |
| increased level of risk | 4 |
| blood | 4 |
| safety of subjects | 4 |
| premarket approval | 4 |
| more accurate information | 4 |
| population | 4 |
| secretary of health | 4 |
| levels of payment | 4 |
| approval period | 4 |
| departments | 4 |
| accurate | 4 |
| test | 4 |
| uiuc researchers | 4 |
| dockets management branch | 4 |
| prevention | 4 |
| biological product | 4 |
| food quality evaluation | 4 |
| diagnostic purposes | 4 |
| work | 4 |
| prolongation | 4 |
| declaration of helsinki | 4 |
| written notification | 4 |
| diagnostic specimens | 4 |
| script | 4 |
| delegated | 4 |
| inadequate | 4 |
| stage | 4 |
| hospitalization | 4 |
| source | 4 |
| interests | 4 |
| adequate review of research activities | 4 |
| bioavailability | 4 |
| facilities | 4 |
| competence | 4 |
| noted | 4 |
| rm | 4 |
| 46.101 | 4 |
| sign | 4 |
| incompetence | 4 |
| beneficial research | 4 |
| efforts | 4 |
| parental permission | 4 |
| failure | 4 |
| show | 4 |
| commitments | 4 |
| ages | 4 |
| contract research organization | 4 |
| awareness | 4 |
| identifiable | 4 |
| additional safeguards | 4 |
| may 22 | 4 |
| uiuc department | 4 |
| significant change | 4 |
| 1976 | 4 |
| heartbeat | 4 |
| intern | 4 |
| unreasonable | 4 |
| classroom | 4 |
| mar. 29 | 4 |
| audio tapes | 4 |
| agricultural chemical | 4 |
| diversity | 4 |
| experimental | 4 |
| environment | 4 |
| responsible principal investigator | 4 |
| appropriate experts | 4 |
| own employees | 4 |
| award | 4 |
| other therapy | 4 |
| course description | 4 |
| informed consent requirements | 4 |
| potential subjects | 4 |
| uiuc investigator handbook | 4 |
| subject recruitment | 4 |
| confusing | 4 |
| consultants | 4 |
| one year | 4 |
| regulatory hearing | 4 |
| disposition | 4 |
| full board | 4 |
| features | 4 |
| neonate | 4 |
| component | 4 |
| jurisdiction | 4 |
| human subject research | 4 |
| requests | 4 |
| appropriate justification | 4 |
| 50.25 | 4 |
| new subjects | 4 |
| demonstration projects | 4 |
| research population | 4 |
| ethical issues | 4 |
| biological products | 4 |
| irb chair | 4 |
| experiences | 4 |
| dates | 4 |
| md 20857 | 4 |
| such information | 4 |
| exceptions | 4 |
| clinical research | 4 |
| benefits of research | 4 |
| bear | 4 |
| applicable regulations | 4 |
| standard | 4 |
| someone | 4 |
| basic elements | 4 |
| intended use | 4 |
| rest | 4 |
| exclusion criteria | 4 |
| constraints | 4 |
| demonstration project | 4 |
| breach | 4 |
| viability | 4 |
| 2003 | 4 |
| 21 u.s.c. | 4 |
| congenital | 4 |
| significant risk | 4 |
| written consent form | 4 |
| public office | 4 |
| agreements | 4 |
| monitor | 4 |
| goal | 4 |
| mind | 4 |
| subsequent | 4 |
| facility | 4 |
| requirements of paragraph | 4 |
| relevant information | 4 |
| research staff | 4 |
| freedom of information act | 4 |
| images | 4 |
| minors | 4 |
| return | 4 |
| variety | 4 |
| 5 working days | 4 |
| rockville | 4 |
| federal guidelines | 4 |
| research plan | 4 |
| subject population | 4 |
| problem | 4 |
| withdrawal | 4 |
| reasonable expectation | 4 |
| telephone | 4 |
| 1988 | 4 |
| following statement | 4 |
| determination of exemption | 4 |
| guardians | 4 |
| irb membership | 4 |
| subpart a | 4 |
| educational practices | 4 |
| deficiencies | 4 |
| justification | 4 |
| new drug | 4 |
| costs | 4 |
| areas | 4 |
| 2 years | 4 |
| half | 4 |
| reference | 4 |
| future | 4 |
| limits | 4 |
| pathological specimens | 4 |
| team of individuals | 4 |
| human | 4 |
| large | 4 |
| only record | 4 |
| notes | 4 |
| possible changes | 4 |
| welfare of subjects | 4 |
| transfer | 4 |
| relationships | 4 |
| preparation | 4 |
| recruiting | 4 |
| next irb meeting | 4 |
| federal statute | 4 |
| proposed | 4 |
| protocol amendment | 4 |
| other institutions | 4 |
| effective date | 4 |
| outline | 4 |
| 52 stat. 1040 | 4 |
| fda approval | 4 |
| conflict | 4 |
| 1993 | 4 |
| concerns | 4 |
| embryo | 4 |
| adequate provisions | 4 |
| beneficence | 4 |
| investigational drugs | 4 |
| adverse effects | 4 |
| research participation | 4 |
| risky research | 4 |
| such use | 4 |
| viable | 4 |
| exercise | 4 |
| oprr | 4 |
| period of time | 4 |
| biologics evaluation | 4 |
| light | 4 |
| telephone numbers | 4 |
| basic responsibility | 4 |
| disadvantaged persons | 4 |
| vote | 4 |
| specific research activity | 4 |
| elicit | 4 |
| respiration | 4 |
| jan. 5 | 4 |
| qualifications | 4 |
| inconvenience | 4 |
| inducements | 4 |
| selection of research subjects | 4 |
| sufficient detail | 4 |
| following conditions | 4 |
| medical treatment | 4 |
| separate | 4 |
| review of research | 4 |
| preclinical studies | 4 |
| rationale | 4 |
| amendments | 4 |
| speech | 4 |
| 312.23 | 4 |
| past | 4 |
| candidates | 4 |
| marketing | 4 |
| provision | 4 |
| hepatitis | 4 |
| docket number | 4 |
| recipient | 4 |
| public benefit | 4 |
| justice | 4 |
| explicit | 4 |
| exempt research | 4 |
| drug evaluation | 4 |
| officials | 4 |
| five members | 4 |
| treatment use | 4 |
| of participants | 4 |
| time of participation | 4 |
| ct | 4 |
| assent of children | 4 |
| lieu | 4 |
| conflict of interest | 4 |
| unknown | 4 |
| safeguards | 4 |
| opinion | 3 |
| 11 | 3 |
| likelihood | 3 |
| incarceration | 3 |
| 217.333.2670 | 3 |
| public disclosure of data | 3 |
| section 505 | 3 |
| following types of research | 3 |
| deliberations | 3 |
| unused supplies | 3 |
| living human beings | 3 |
| parole | 3 |
| recruitment | 3 |
| other person | 3 |
| significant differences | 3 |
| american anthropological association | 3 |
| certain individuals | 3 |
| users | 3 |
| vulnerable category of subjects | 3 |
| locations | 3 |
| 55 fr 11580 | 3 |
| prisons | 3 |
| major change | 3 |
| material changes | 3 |
| reporters | 3 |
| october 1 | 3 |
| small scale | 3 |
| six categories | 3 |
| community attitudes | 3 |
| aid | 3 |
| established | 3 |
| types | 3 |
| scientific information | 3 |
| ultimate responsibility | 3 |
| identity of subjects | 3 |
| correct. | 3 |
| l | 3 |
| ascertained | 3 |
| animal | 3 |
| campus irb | 3 |
| local requirements | 3 |
| particular protocol | 3 |
| public disclosure | 3 |
| june 18 | 3 |
| faculty appointment | 3 |
| see | 3 |
| research design | 3 |
| identifiable subject information | 3 |
| such investigations | 3 |
| 15 | 3 |
| such advantages | 3 |
| parole boards | 3 |
| adverse effect | 3 |
| disorder | 3 |
| added risk | 3 |
| identity of individuals | 3 |
| attachments | 3 |
| ethnographic research | 3 |
| confirmation | 3 |
| emphasis | 3 |
| organization | 3 |
| collection of data | 3 |
| penal institution | 3 |
| subject physical | 3 |
| research academic policies | 3 |
| injuries | 3 |
| word | 3 |
| prior written authorization | 3 |
| threatening | 3 |
| impairment | 3 |
| printable version available | 3 |
| informed decision | 3 |
| device other | 3 |
| integral part | 3 |
| project. | 3 |
| individual investigators | 3 |
| other irb | 3 |
| diseases | 3 |
| principle of beneficence | 3 |
| umbilical cord | 3 |
| 110 | 3 |
| genders | 3 |
| other images | 3 |
| 67 fr 9586 | 3 |
| cells | 3 |
| quantity | 3 |
| revised protocol | 3 |
| full disclosure | 3 |
| investigational device | 3 |
| disadvantaged | 3 |
| emergency use | 3 |
| u.s. | 3 |
| chance | 3 |
| research participants | 3 |
| classroom management methods | 3 |
| 56.104 | 3 |
| synonymous | 3 |
| nothing | 3 |
| initial review | 3 |
| centers | 3 |
| subject willingness | 3 |
| thesis projects | 3 |
| consequences | 3 |
| primary relationship | 3 |
| us department of agriculture | 3 |
| 812 | 3 |
| written form | 3 |
| full | 3 |
| emergency research | 3 |
| program | 3 |
| american sociological association | 3 |
| judicial | 3 |
| accuracy | 3 |
| need verification | 3 |
| government | 3 |
| major modifications | 3 |
| new cases | 3 |
| appendix a | 3 |
| exempts taste | 3 |
| other group | 3 |
| 1983 | 3 |
| biological | 3 |
| equivalent investigation | 3 |
| indication | 3 |
| treatment protocol | 3 |
| father consent need | 3 |
| many cases | 3 |
| vaccine trials | 3 |
| individual can | 3 |
| full irb discussion | 3 |
| laboratory tests | 3 |
| events | 3 |
| guest investigators | 3 |
| departmental review bodies | 3 |
| association | 3 |
| obvious | 3 |
| samples | 3 |
| detailed guidelines | 3 |
| additional study | 3 |
| compulsion | 3 |
| termination of irb approval | 3 |
| rape | 3 |
| literature | 3 |
| distinctions | 3 |
| review committee | 3 |
| only | 3 |
| father | 3 |
| aims | 3 |
| sufficient time | 3 |
| father need | 3 |
| dec. 2 | 3 |
| community | 3 |
| immune | 3 |
| result of participation | 3 |
| invasion of privacy | 3 |
| phase 2 | 3 |
| available only | 3 |
| statutes | 3 |
| trials | 3 |
| interest | 3 |
| pregnant animals | 3 |
| ethical performance | 3 |
| uiuc policy | 3 |
| infants | 3 |
| accessible | 3 |
| and. | 3 |
| penalty | 3 |
| role | 3 |
| research site | 3 |
| prior review | 3 |
| sufficient data | 3 |
| minutes | 3 |
| dead fetus | 3 |
| january 2003 approved | 3 |
| loss of benefits | 3 |
| required elements | 3 |
| president | 3 |
| categories of research | 3 |
| validity | 3 |
| substances | 3 |
| medical records | 3 |
| required. adverse events | 3 |
| marketing permit | 3 |
| files accessible only | 3 |
| sentencing | 3 |
| methodology | 3 |
| choices | 3 |
| serious disease | 3 |
| certain kinds of research | 3 |
| representatives | 3 |
| foreseeable risks | 3 |
| important biomedical knowledge | 3 |
| instance | 3 |
| section 515 | 3 |
| storage | 3 |
| care of participants | 3 |
| helpful | 3 |
| offer | 3 |
| of prisoners | 3 |
| available prisoners | 3 |
| hhs guidelines | 3 |
| sentences | 3 |
| registrants | 3 |
| funds | 3 |
| of unavailability | 3 |
| legal status | 3 |
| investigator obtains | 3 |
| other parties | 3 |
| offices | 3 |
| previous irb review | 3 |
| evaluations | 3 |
| 1974 | 3 |
| two general rules | 3 |
| quality of life | 3 |
| summary statement | 3 |
| requirements of subparts | 3 |
| research records | 3 |
| incest | 3 |
| official university course catalogue | 3 |
| outside institutions | 3 |
| investigator noncompliance | 3 |
| different purposes | 3 |
| equal | 3 |
| use of facilities | 3 |
| alteration provisions | 3 |
| serious adverse events | 3 |
| possible advantages | 3 |
| principle | 3 |
| such activities | 3 |
| new site | 3 |
| appendix b | 3 |
| english | 3 |
| preclinical | 3 |
| mere failure | 3 |
| neglect | 3 |
| culture | 3 |
| irb reviews | 3 |
| technical language | 3 |
| 61 fr 51529 | 3 |
| entities | 3 |
| dental | 3 |
| shipments | 3 |
| signs | 3 |
| qualified personnel | 3 |
| nonviable neonate | 3 |
| federal requirements | 3 |
| advantages | 3 |
| marketing permits | 3 |
| 45 cfr 46.111 | 3 |
| addenda | 3 |
| reasonable probability | 3 |
| emergency medical care | 3 |
| pilot projects | 3 |
| exemption 5 | 3 |
| four | 3 |
| labels | 3 |
| young children | 3 |
| other formal uiuc policy documents | 3 |
| duty | 3 |
| focus | 3 |
| temporary incapacity | 3 |
| 2006 | 3 |
| human subjects forms | 3 |
| excessive inducement | 3 |
| counsel | 3 |
| subjects cannot | 3 |
| code mark | 3 |
| nuremberg code | 3 |
| research protocols | 3 |
| own initiative | 3 |
| instructors | 3 |
| declaration | 3 |
| apprise | 3 |
| point of viability | 3 |
| prison authorities | 3 |
| available scientific evidence | 3 |
| stable | 3 |
| long periods of time | 3 |
| sex | 3 |
| department head | 3 |
| disciplines | 3 |
| significant risk device | 3 |
| devices form | 3 |
| useful | 3 |
| local law | 3 |
| woman | 3 |
| 1994 | 3 |
| explicit consent | 3 |
| degree | 3 |
| behavioral conditions | 3 |
| prescription | 3 |
| meaningful | 3 |
| planned | 3 |
| purview | 3 |
| insufficient evidence of safety | 3 |
| other terms | 3 |
| appropriate alternative procedures | 3 |
| dean | 3 |
| following protocol | 3 |
| normal educational practices | 3 |
| anticipated circumstances | 3 |
| new use | 3 |
| prior approval | 3 |
| exclusion | 3 |
| irb committee | 3 |
| specific research activities | 3 |
| race | 3 |
| basic confidentiality requirement | 3 |
| review process | 3 |
| full board review | 3 |
| experimental protocol | 3 |
| 45 cfr 46.102 | 3 |
| section 520 | 3 |
| 50.23 | 3 |
| racial | 3 |
| such form | 3 |
| adequate information | 3 |
| deviation | 3 |
| limited choice environment | 3 |
| 5 days | 3 |
| uiuc irb. | 3 |
| expedited | 3 |
| therein. student | 3 |
| information amendment | 3 |
| inadequate consent forms | 3 |
| consultant | 3 |
| course of study | 3 |
| funding source | 3 |
| response | 3 |
| original | 3 |
| diagnostic procedure | 3 |
| research data | 3 |
| provisions of subpart d | 3 |
| legal responsibility | 3 |
| implantation | 3 |
| 46.102 | 3 |
| telephone number | 3 |
| n | 3 |
| approach | 3 |
| implicit | 3 |
| use of interviews | 3 |
| such prospect of benefit | 3 |
| 50.27 | 3 |
| money | 3 |
| product of conception | 3 |
| nov. 5 | 3 |
| control subjects | 3 |
| curriculum development | 3 |
| intended patient population | 3 |
| subject consent | 3 |
| interactions | 3 |
| reasonable basis | 3 |
| research. | 3 |
| beneficial | 3 |
| living humans | 3 |
| medical treatments | 3 |
| provisions of sec | 3 |
| views | 3 |
| risks of harm | 3 |
| quality of food | 3 |
| informed consent form | 3 |
| child parents | 3 |
| complications | 3 |
| sensitivity | 3 |
| uiuc irbs | 3 |
| placenta | 3 |
| general statement | 3 |
| regular basis | 3 |
| processing | 3 |
| processes of incarceration | 3 |
| curricula | 3 |
| increase | 3 |
| criminal behavior | 3 |
| elder abuse | 3 |
| finding | 3 |
| psychological harm | 3 |
| irb information | 3 |
| listing | 3 |
| psychological problems such | 3 |
| sabbatical researchers | 3 |
| loss of confidentiality | 3 |
| project other investigator | 3 |
| controlled clinical trial | 3 |
| cultural backgrounds | 3 |
| reasonable likelihood | 3 |
| videos | 3 |
| 312.30 | 3 |
| federal department | 3 |
| incarcerated persons | 3 |
| anyone responsible | 3 |
| common | 3 |
| direction | 3 |
| such examination | 3 |
| experiments | 3 |
| average participant level of understanding | 3 |
| other procedures | 3 |
| professional conduct | 3 |
| other body | 3 |
| data analysis | 3 |
| valid | 3 |
| additional data | 3 |
| absent affirmative agreement | 3 |
| phase 3 studies | 3 |
| eligibility | 3 |
| personal information | 3 |
| topics | 3 |
| additional consent | 3 |
| misleading | 3 |
| of title 21 | 3 |
| prison | 3 |
| student subject pool | 3 |
| earnings | 3 |
| degree program | 3 |
| exempts research | 3 |
| specific | 3 |
| private entity | 3 |
| discomforts | 3 |
| health care | 3 |
| visit | 3 |
| representative need | 3 |
| minor modifications | 3 |
| viable neonates | 3 |
| nonviable neonates | 3 |
| behavioral | 3 |
| pregnancy | 3 |
| foreseeable impact | 3 |
| liability | 3 |
| further information | 3 |
| human subjects protocol | 3 |
| 12 | 3 |
| written statement | 3 |
| review decision | 3 |
| unavailable | 3 |
| benefits of participation | 3 |
| jan. 18 | 3 |
| following essential elements | 3 |
| 45 cfr 46.101 | 3 |
| illinois | 3 |
| directors | 3 |
| study progress. | 3 |
| www.irb.uiuc.edu | 3 |
| following additional conditions | 3 |
| only means | 3 |
| regular | 3 |
| 67 fr 9585 | 3 |
| approved cases | 3 |
| comments | 3 |
| divulge unique | 3 |
| 10 | 3 |
| prospective subjects | 3 |
| oct. 20 | 3 |
| federalwide assurance | 3 |
| second | 3 |
| treatment ind | 3 |
| advantageous | 3 |
| certain other hhs requirements | 3 |
| 3 years | 3 |
| medical research | 3 |
| scripts | 3 |
| individual prisoners | 3 |
| call | 3 |
| relevant attachments | 3 |
| such determination | 3 |
| inappropriate | 3 |
| organs | 3 |
| diet | 3 |
| interview schedules | 3 |
| uncertain viability | 3 |
| involvement of subjects | 3 |
| unnecessary | 3 |
| hypotheses | 3 |
| other correspondence | 3 |
| premises | 3 |
| probability of survival | 3 |
| parts 50 | 3 |
| 63 fr 66669 | 3 |
| more frequent | 3 |
| timetable | 3 |
| recording | 3 |
| basis of favoritism | 3 |
| postdoctoral | 3 |
| significant additional risk of illness | 3 |
| research equipment form | 3 |
| commitment procedures | 3 |
| 45 fr 3751 | 3 |
| additional protections | 3 |
| prisoner participation | 3 |
| exposure | 3 |
| courses of treatment | 3 |
| minutes of irb meetings | 3 |
| components | 3 |
| placebo | 3 |
| educational settings | 3 |
| ill patients | 3 |
| pediatric studies | 3 |
| exemption 2 | 3 |
| field | 3 |
| other agencies | 3 |
| university | 3 |
| staff report | 3 |
| approvals | 3 |
| data collection | 3 |
| wards | 3 |
| 61 fr 57280 | 3 |
| criminal prosecution | 3 |
| incentives | 3 |
| relevant forms | 3 |
| officer | 3 |
| other purposes | 3 |
| deceit | 3 |
| pervasive | 3 |
| area | 3 |
| own environment | 3 |
| special education instructional strategies | 3 |
| 56.109 | 3 |
| demonstration | 3 |
| available information | 3 |
| view | 3 |
| arraignment | 3 |
| terminology | 3 |
| herein | 3 |
| corporation | 3 |
| comprehensive written document | 3 |
| specific purposes | 3 |
| answer | 3 |
| human subjects research activity | 3 |
| grades | 3 |
| more human subjects | 3 |
| penology | 3 |
| more prevalent | 3 |
| arbitrary intervention | 3 |
| other facilities | 3 |
| neonates | 3 |
| possible causes | 3 |
| animals | 3 |
| research setting | 3 |
| uiuc students | 3 |
| free choice | 3 |
| agenda | 3 |
| less powerful | 3 |
| cognizant | 3 |
| instruments | 3 |
| public use | 3 |
| signature | 3 |
| volunteers | 3 |
| outcome | 3 |
| custody | 3 |
| schools | 3 |
| monetary | 3 |
| accepted | 3 |
| formulation | 3 |
| 56.110 | 3 |
| significant protocol changes | 3 |
| institutional structures | 3 |
| willing | 3 |
| edition | 3 |
| assignment of prisoners | 3 |
| patient population | 3 |
| sexual assaults | 3 |
| intellectual property | 3 |
| informed consent provisions of subpart | 3 |
| future relations | 3 |
| person signing | 3 |
| presence | 3 |
| other relevant information | 3 |
| prospect of benefit | 3 |
| part 601 | 3 |
| express permission | 3 |
| following statement of policy applicable | 3 |
| exemption 5 cannot | 3 |
| state of illinois | 3 |
| more sensitive | 3 |
| immediate family | 3 |
| world wide web | 3 |
| interested | 3 |
| anticipated | 3 |
| aim | 3 |
| m | 3 |
| instructional techniques | 3 |
| considerations | 3 |
| such images | 3 |
| lengths | 3 |
| equivalent clinical investigation | 3 |
| subject comprehension | 3 |
| vital functions | 3 |
| subject identity | 3 |
| pregnant woman | 3 |
| prisoner | 3 |
| 22 | 3 |
| amenities | 3 |
| informed consent documents | 3 |
| likeness | 3 |
| organizations | 3 |
| other unique | 3 |
| appropriateness | 3 |
| diagnosis | 3 |
| of men | 3 |
| adoption | 3 |
| student dissertation | 3 |
| such guidelines | 3 |
| average american adult | 3 |
| certain activities | 3 |
| foreign | 3 |
| private information | 3 |
| human tissues | 3 |
| subject face | 3 |
| sites | 3 |
| persons knowledgeable | 3 |
| drug effectiveness | 3 |
| bethesda | 3 |
| same meaning | 3 |
| apparent immediate hazards | 3 |
| innovative | 3 |
| washington | 3 |
| systematic investigation | 3 |
| nondiscriminatory effort | 3 |
| oversight | 3 |
| recruiting subjects | 3 |
| state law | 3 |
| 14 | 3 |
| certain minimal risk projects | 3 |
| capable of assent | 3 |
| principles of respect | 3 |
| willingness | 3 |
| comprehension | 3 |
| laboratory | 3 |
| agency heads | 3 |
| chancellor | 3 |
| sources | 3 |
| statement such | 3 |
| consideration of race | 3 |
| confidential | 3 |
| radioactive drugs | 3 |
| other federal departments | 3 |
| other tests | 3 |
| investigator brochure | 3 |
| expedited cases | 3 |
| top 3 | 3 |
| attention | 3 |
| average subject reading level | 3 |
| professional competence necessary | 3 |
| menses | 3 |
| original consent | 3 |
| independent study projects | 3 |
| significant disability | 3 |
| control group | 3 |
| interpersonal contact | 3 |
| regulatory sections | 3 |
| adjunct appointments | 3 |
| reasonable manner | 3 |
| week | 3 |
| general living conditions | 3 |
| amendment | 3 |
| nonpregnant women | 3 |
| complete review | 3 |